Vancomycin and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Vancomycin (vancomycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Levofloxacin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Icterus when taking Vancomycin. It is created by eHealthMe based on reports of 17,160 people who have side effects when taking Vancomycin from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 1,966 drugs and 3,030 conditions by eHealthMe. Check the latest studies of Icterus.

On Jun, 01, 2026

17,160 people reported to have side effects when taking Vancomycin.
Among them, 34 people (0.2%) have Icterus.

Among these 34 people:

How long have people been on Vancomycin when they have Icterus? *

What is the gender of people who have Icterus when taking Vancomycin? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Icterus when taking Vancomycin? *

What are other drugs people take besides Vancomycin? *

What are other side effects people have besides Icterus? *

Hyperbilirubinaemia (excess of bilirubin in the blood): 23 people, 67.65%
Hepatic Enzyme Increased: 3 people, 8.82%
Septic Shock (shock due to blood infection): 3 people, 8.82%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 8.82%
Fungaemia (fungi circulate in the blood): 2 people, 5.88%
Drug Ineffective: 2 people, 5.88%
Trichosporon Infection (a fungal infection by trichophyton): 2 people, 5.88%
Hepatotoxicity (chemical-driven liver damage): 2 people, 5.88%
Hypotension (abnormally low blood pressure): 2 people, 5.88%
Confusion: 2 people, 5.88%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 20 people, 58.82%
Systemic Candida (whole body fungal infection): 19 people, 55.88%
Sepsis (a severe blood infection that can lead to organ failure and death): 19 people, 55.88%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 5.88%
Fever: 2 people, 5.88%
T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 2 people, 5.88%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.88%
Testis Cancer (testes cancer): 2 people, 5.88%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.94%
Bone Tuberculosis: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin:

Vancomycin (17,165 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (1,966 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (3,030 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin (the active ingredients of Vancomycin) and Vancomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.